New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model Schlieren, Switzerland – InSphero AG, the global leader in 3D cell-based assays and organ-on-chip systems, today announced the commercial launch of the 3D InSight™ Drug-Induced Gastrointestinal Toxicity (DIGIT) platform, a standardized, high-throughput screening solution for early assessment of gastrointestinal liabilities in drug discovery. […]

Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia ™Platform ·       Proceeds will help enhance workflows and expand single-cell functional assay portfolio ·       Brad Crutchfield joins as advisor to support early access growth and  global launch CAMBRIDGE, England – Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced […]

North Brunswick, NJ – Distek, Inc., a leading provider of pharmaceutical and bioprocessing instrumentation, announced an exclusive manufacturers’ representative agreement with Optimal Biotech Group, LLC to support its BIOne benchtop bioreactor solutions across California, Oregon, and Washington. Through this agreement, Optimal Biotech Group will represent Distek’s BIOne portfolio, including the BIOne 250 and BIOne 1250 Bioreactor […]

Rapid preselection of high-producing clones from candidate pools, saving resources Monoclonality verification with automated documentation for full traceability Up to 100 percent transfer efficiency and viability to protect top clones for downstream expansion  Göttingen, Germany — Sartorius announces the launch of the CellCelector CLD, an automated imaging and cell isolation platform designed to simplify and accelerate […]

Partnership Delivers RoosterBio’s Research-Grade and CliniControl™ cGMP Media Platforms to China’s Leading Cell and Gene Therapy Developers; MineBio Holds Import Approval for Immediate Order Fulfillment FREDERICK, MD. — RoosterBio, Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered bioprocess media, and advanced therapy manufacturing solutions for hMSCs and exosomes, today announced an […]

CAMBRIDGE, Mass. and SAN FRANCISCO, Calif. – Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate Kytopen’s global commercial expansion and drive further adoption of its Flowfect® technology platform across the U.S. and Europe. […]

David P. King nominated to support next phase of growth and innovation; Frances Arnold, Robert S. Epstein, and Gary S. Guthart to retire from the Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced changes to its Board of Directors. Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart, PhD, will retire from the Board in connection with the company’s upcoming […]

Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibco™ CTS™ Compleo™ Fill and Finish System, an automated, functionally closed solution designed to streamline formulation and filling […]

Gibco CHOvantage GS Cell Line Development Kit delivers high productivity, streamlined timelines and royalty-free, clinical-stage licensing options to support scalable manufacturing. WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Executive Vice President and Chief Financial Officer (CFO), R. Brent Jones, will leave the Company on or before June 24, 2026. Avantor has initiated a search to […]